206 related articles for article (PubMed ID: 15046712)
21. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
[TBL] [Abstract][Full Text] [Related]
22. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
[TBL] [Abstract][Full Text] [Related]
23. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
[TBL] [Abstract][Full Text] [Related]
24. Molecular staging of prostate cancer: dream or reality?
de la Taille A; Olsson CA; Katz AE
Oncology (Williston Park); 1999 Feb; 13(2):187-94; discussion 194-8, 204-5 pas. PubMed ID: 10079469
[TBL] [Abstract][Full Text] [Related]
25. Reverse transcriptase-polymerase chain reaction assays for prostate cancer.
Olsson CA; de Vries GM; Buttyan R; Katz AE
Urol Clin North Am; 1997 May; 24(2):367-78. PubMed ID: 9126234
[TBL] [Abstract][Full Text] [Related]
26. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
27. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
[TBL] [Abstract][Full Text] [Related]
28. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
31. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
32. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer.
Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH
Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609
[TBL] [Abstract][Full Text] [Related]
33. Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts biochemical recurrence after radical prostatectomy.
Okegawa T; Nutahara K; Higashihara E
BJU Int; 1999 Jul; 84(1):112-7. PubMed ID: 10444137
[TBL] [Abstract][Full Text] [Related]
34. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy.
Straub B; Müller M; Krause H; Goessl C; Schrader M; Heicappell R; Miller K
Urology; 2001 May; 57(5):1006-11. PubMed ID: 11337316
[TBL] [Abstract][Full Text] [Related]
35. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
Koutsilieris M; Lembessis P; Luu-The V; Sourla A
Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
[TBL] [Abstract][Full Text] [Related]
36. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer.
Katz AE; de Vries GM; Begg MD; Raffo AJ; Cama C; O'Toole K; Buttyan R; Benson MC; Olsson CA
Cancer; 1995 Apr; 75(7):1642-8. PubMed ID: 8826922
[TBL] [Abstract][Full Text] [Related]
37. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
38. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy.
Ogawa O; Iinuma M; Sato K; Sasaki R; Shimoda N; Satoh S; Kato T
Urol Res; 1999 Aug; 27(4):291-6. PubMed ID: 10460902
[TBL] [Abstract][Full Text] [Related]
39. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy.
Theodorescu D; Frierson HF; Sikes RA
J Urol; 1999 May; 161(5):1442-8. PubMed ID: 10210369
[TBL] [Abstract][Full Text] [Related]
40. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
